Appendix E - National Coverage Determinations Manual / ISLET_CELL_TRANSPLANTATION_IN_THE_CONTEXT_OF_A_CLINICAL_TRIAL

Why This Topic Matters

It helps readers determine whether services associated with pancreatic islet cell transplantation may be covered by Medicare when provided under the stated clinical trial framework, and whether the policy excludes services performed outside that context.

Article Sections

1. A. General

   Provides background on the policy basis, the clinical context for pancreatic islet cell transplantation, and the general patient and procedure setting addressed by the determination.

2. B. Nationally Covered Indications

   Summarizes the Medicare-covered services and the general trial participation framework described in the determination, including related care categories tied to the covered setting.

3. C. Nationally Noncovered Indications

   States the circumstances in which the transplantation service is not covered under this policy.

4. D. Other

   Includes administrative closing information and review status details for the determination.